+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Microbiome Sequencing Market- Product Image
Microbiome Sequencing Market- Product Image
New

Microbiome Sequencing Market

  • PDF Icon

    Report

  • 124 Pages
  • May 2025
  • Region: Global
  • BCC Research
  • ID: 6091043
Description Jump to:
The global microbiome sequencing market is expected to grow from $1.5 billion in 2024 and is projected to reach $3.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 19.3% during the forecast period of 2024 to 2029.

Next-generation sequencing (NGS) technologies have transformed the discipline by providing high-throughput, affordable analysis of microbial communities with the ability to sequence millions of DNA fragments at once. By combining microbiome data with genomics, proteomics and metabolomics, researchers have gained a full understanding of microbial functions in health and disease. In addition, the creation of smaller, less expensive sequencing instruments, such as Illumina's MiSeq i100 line, has placed sequencing technologies within reach of smaller research and clinical labs. Organizations are making significant investments in R&D to create affordable sequencing platforms, bioinformatics software and data analysis solutions enabled by AI to enhance precision and efficiency. Strategic partnerships and grants also enhance research in microbiomes, leading to the development of new applications in precision medicine and microbiome therapeutics.

Report Scope

The report analyzes the microbiome sequencing market by component, sequencing technology, laboratory type, application and end user, offering insights into key trends and growth drivers. The study concludes with an analysis of leading companies and their offerings. The base year for the study is 2023, the estimated year is 2024 with projections through 2029, including compound annual growth rate (CAGR) for the forecast period.

This report analyzes the macroeconomic factors affecting the market. Market drivers, restraints and opportunities are identified. The report covers the regulatory landscape, recent technologies and patents in the market, as well as innovations in products and performance. The report also covers the competitive landscape, ESG factors and profiles of leading companies.

Regional analysis covers North America (U.S., Canada and Mexico), Europe (U.K., Germany, France, Italy, Spain and Rest of Europe), Asia-Pacific (Japan, China, India, South Korea, Australia and Rest of Asia-Pacific), Middle East and Africa (MEA) and South America (Brazil, Argentina and Rest of South America).

The report includes:

  • 50 data tables and 51 additional tables
  • Analyses of the global market trends for microbiome sequencing technologies, with revenue data from 2021-2024, and projected CAGRs through 2029
  • Estimates of the size and revenue prospects for the global market, along with a market share analysis by sequencing technology, component, laboratory type, application, end user and region
  • Facts and figures pertaining to the market dynamics, technological advances, regulations, and the impact of macroeconomic factors
  • Insights derived from the Porter’s Five Forces model, as well as global supply chain and PESTLE analyses
  • A look at the emerging trends and opportunities in microbiome-based therapeutics, clinical trials
  • Evaluation of recent patent activity and key granted and published patents
  • Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and the ESG scores and practices of leading companies
  • Analysis of the industry structure, including companies’ market shares and rankings, strategic alliances, M&A activity and a venture funding outlook
  • Profiles of leading companies including Illumina Inc., Qiagen, Thermo Fisher Scientific Inc., Oxford Nanopore Technologies Plc., and PacBio.

Table of Contents

Chapter 1 Executive Summary
  • Market Outlook
  • Scope of Report
  • Market Summary
Chapter 2 Market Overview
  • Overview
  • Outlook
  • Macroeconomic Analysis
  • Impact of U.S.-China Trade War
Chapter 3 Market Dynamics
  • Market Drivers
  • Decreasing Cost per Genome
  • Government Initiatives and Funding
  • Advances in Sequencing Technology
  • Market Restraints
  • Data Complexity and Bioinformatics Challenges
  • Lack of Standardized Protocols and Reference Databases
  • Lack of Grant Funding
  • Market Opportunities
  • Personalized Medicine and Diagnostics
  • Drug Discovery and Development
  • Agriculture and the Food Industry
Chapter 4 Regulatory Landscape
  • Overview
Chapter 5 Emerging Technologies and Patent Analysis
  • Emerging Technologies
  • Nanopore Sequencing
  • SMRT Sequencing
  • FACS with Microfluidics
  • Metatranscriptome Sequencing
  • Patent Analysis
  • Regional Patterns
Chapter 6 Market Segment Analysis
  • Market Trends
  • Segmentation Breakdown
  • Microbiome Sequencing: Global Markets
  • Market Analysis by Sequencing Technology
  • High-throughput Sequencing
  • Sanger Sequencing
  • Third-Generation Sequencing
  • Market Analysis by Component
  • Reagents and Kits
  • Instruments
  • Market Analysis by Laboratory Type
  • Wet Labs
  • Dry Labs
  • Market Analysis by Application
  • Disease Diagnosis Research
  • Personalized Medicine
  • Drug Discovery
  • Genetic Screening
  • Other Applications
  • Market Analysis by End User
  • Pharmaceutical and Biotechnology
  • Academic Centers and Research Institutes
  • Other End Users
  • Geographic Breakdown
  • Market Breakdown by Region
  • North America
  • Europe
  • Asia-Pacific
  • MEA
  • South America
Chapter 7 Competitive Landscape
  • Key Suppliers and Manufacturers
  • Ranking of Companies in the Microbiome Sequencing Industry
  • Strategic Analysis
Chapter 8 Environmental, Social, and Governance (ESG) Perspective
  • Sustainability in the Microbiome Sequencing Market
  • ESG Risks and Ratings: Understanding the Data
  • Analyst's Viewpoint
Chapter 9 Appendix
  • Research Methodology
  • Sources
  • Abbreviations
  • Company Profiles
  • BASECLEAR BV
  • CD GENOMICS
  • CHARLES RIVER LABORATORIES
  • COSMOSID
  • CROWN BIOSCIENCE
  • DANAHER CORP.
  • EUROFINS SCIENTIFIC
  • ILLUMINA INC.
  • MERIEUX NUTRISCIENCES
  • MICROBIOME INSIGHTS
  • NOVOGENE CO. LTD.
  • OXFORD NANOPORE TECHNOLOGIES PLC
  • PACBIO
  • QIAGEN
  • THERMO FISHER SCIENTIFIC INC.
  • Emerging Startups
  • Pendulum
  • Microba
  • Biomesense
List of Tables
Summary Table: Global Market for Microbiome Sequencing, by Region, Through 2029
Table 1: Cost Per Genome, 2019-2022
Table 2: FDA-Approved Personalized Medicines, 2015-2022
Table 3: Regulatory Scenario for Microbiome Sequencing, by Country
Table 4: Global Market for Microbiome Sequencing, Through 2029
Table 5: Global Market for Microbiome Sequencing, by Sequencing Technology, Through 2029
Table 6: NGS Technologies
Table 7: Experimental HTS Technology
Table 8: Illumina’s Two-Channel SBS Instruments
Table 9: Comparison of Sanger Sequencing and Targeted NGS
Table 10: Global Market for Microbiome Sequencing, by Component, Through 2029
Table 11: Pricing of Microbiome Products, by Company
Table 12: Global Market for Microbiome Sequencing, by Laboratory Type, Through 2029
Table 13: Global Market for Microbiome Sequencing, by Application, Through 2029
Table 14: Global Market for Microbiome Sequencing Market, by End User, Through 2029
Table 15: Partnerships between Biotech and Pharma Companies for Microbiome Projects
Table 16: Academic Centers and Research Institutes Engaged in Microbiome Research
Table 17: Global Market for Microbiome Sequencing, by Region, Through 2029
Table 18: North American Market for Microbiome Sequencing, by Country, Through 2029
Table 19: North American Market for Microbiome Sequencing, by Sequencing Technology, Through 2029
Table 20: North American Market for Microbiome Sequencing, by Component, Through 2029
Table 21: North American Market for Microbiome Sequencing, by Laboratory Type, Through 2029
Table 22: North American Market for Microbiome Sequencing, by Application, Through 2029
Table 23: North American Market for Microbiome Sequencing, by End User, Through 2029
Table 24: European Market for Microbiome Sequencing, by Country, Through 2029
Table 25: European Market for Microbiome Sequencing, by Sequencing Technology, Through 2029
Table 26: European Market for Microbiome Sequencing, by Component, Through 2029
Table 27: European Market for Microbiome Sequencing, by Laboratory Type, Through 2029
Table 28: European Market for Microbiome Sequencing, by Application, Through 2029
Table 29: European Market for Microbiome Sequencing, by End User, Through 2029
Table 30: Asia-Pacific Market for Microbiome Sequencing, by Country, Through 2029
Table 31: Asia-Pacific Market for Microbiome Sequencing, by Sequencing Technology, Through 2029
Table 32: Asia-Pacific Market for Microbiome Sequencing, by Component, Through 2029
Table 33: Asia-Pacific Market for Microbiome Sequencing, by Laboratory Type, Through 2029
Table 34: Asia-Pacific Market for Microbiome Sequencing, by Application, Through 2029
Table 35: Asia-Pacific Market for Microbiome Sequencing, by End User, Through 2029
Table 36: MEA Market for Microbiome Sequencing, by Region, Through 2029
Table 37: MEA Market for Microbiome Sequencing, by Sequencing Technology, Through 2029
Table 38: MEA Market for Microbiome Sequencing, by Component, Through 2029
Table 39: MEA Market for Microbiome Sequencing, by Laboratory Type, Through 2029
Table 40: MEA Market for Microbiome Sequencing, by Application, Through 2029
Table 41: MEA Market for Microbiome Sequencing, by End User, Through 2029
Table 42: South American Market for Microbiome Sequencing, by Country, Through 2029
Table 43: South American Market for Microbiome Sequencing, by Sequencing Technology, Through 2029
Table 44: South American Market for Microbiome Sequencing, by Component, Through 2029
Table 45: South American Market for Microbiome Sequencing, by Laboratory Type, Through 2029
Table 46: South American Market for Microbiome Sequencing, by Application, Through 2029
Table 47: South American Market for Microbiome Sequencing, by End User, Through 2029
Table 48: Ranking of Leading Companies in the Microbiome Sequencing Industry, 2023
Table 49: Strategic Analysis in the Microbiome Sequencing Industry
Table 50: ESG Rankings for Major Microbiome Sequencing Companies*
Table 51: Information Sources for This Report
Table 52: Abbreviations Used in the Report
Table 53: BaseClear BV: Company Snapshot
Table 54: BaseClear BV: Product Portfolio
Table 55: CD Genomics: Company Snapshot
Table 56: CD Genomics: Product Portfolio
Table 57: Charles River Laboratories: Company Snapshot
Table 58: Charles River Laboratories: Financial Performance, FY 2023 and 2024
Table 59: Charles River Laboratories: Product Portfolio
Table 60: Charles River Laboratories: News/Key Developments, 2023
Table 61: CosmosID: Company Snapshot
Table 62: CosmosID: Product Portfolio
Table 63: CosmosID: News/Key Developments, 2022
Table 64: Crown Bioscience: Company Snapshot
Table 65: Crown Bioscience: Product Portfolio
Table 66: Danaher Corp.: Company Snapshot
Table 67: Danaher Corp.: Financial Performance, FY 2023 and 2024
Table 68: Danaher Corp.: Product Portfolio
Table 69: Danaher Corp.: News/Key Developments, 2024
Table 70: Eurofins Scientific: Company Snapshot
Table 71: Eurofins Scientific: Financial Performance, FY 2022 and 2023
Table 72: Eurofins Scientific: Product Portfolio
Table 73: Illumina Inc.: Company Snapshot
Table 74: Illumina Inc.: Financial Performance, FY 2023 and 2024
Table 75: Illumina Inc.: Product Portfolio
Table 76: Illumina Inc.: News/Key Developments, 2022-2025
Table 77: Merieux NutriSciences: Company Snapshot
Table 78: Merieux NutriSciences: Product Portfolio
Table 79: Microbiome Insights: Company Snapshot
Table 80: Microbiome Insights: Product Portfolio
Table 81: Microbiome Insights: News/Key Developments, 2024
Table 82: Novogene Co. Ltd.: Company Snapshot
Table 83: Novogene Co. Ltd.: Financial Performance, FY 2023 and 2024
Table 84: Novogene Co. Ltd.: Product Portfolio
Table 85: Oxford Nanopore Technologies plc: Company Snapshot
Table 86: Oxford Nanopore Technologies plc: Financial Performance, FY 2023 and 2024
Table 87: Oxford Nanopore Technologies plc: Product Portfolio
Table 88: Oxford Nanopore Technologies plc: News/Key Developments, 2024
Table 89: PacBio: Company Snapshot
Table 90: PacBio: Financial Performance, FY 2023 and 2024
Table 91: PacBio: Product Portfolio
Table 92: PacBio: News/Key Developments, 2023 and 2024
Table 93: QIAGEN: Company Snapshot
Table 94: QIAGEN: Financial Performance, FY 2022 and 2023
Table 95: QIAGEN: Product Portfolio
Table 96: QIAGEN: News/Key Developments, 2024
Table 97: Thermo Fisher Scientific Inc.: Company Snapshot
Table 98: Thermo Fisher Scientific Inc.: Financial Performance, FY 2023 and 2024
Table 99: Thermo Fisher Scientific Inc.: Product Portfolio
Table 100: Thermo Fisher Scientific Inc.: News/Key Developments, 2023
List of Figures
Summary Figure: Global Market Shares of Microbiome Sequencing, by Region, 2023
Figure 1: Market Dynamics
Figure 2: Emerging Technologies in Microbiome Sequencing
Figure 3: Global Market Shares for Microbiome Sequencing, by Sequencing Technology, 2023
Figure 4: Global Market Shares for Microbiome Sequencing, by Sequencing Technology, 2023
Figure 5: Global Market Shares for Microbiome Sequencing, by Component, 2023
Figure 6: Global Market Shares for Microbiome Sequencing, by Laboratory Type, 2023
Figure 7: Global Market Shares for Microbiome Sequencing, by Application, 2023
Figure 8: Global Market Shares for Microbiome Sequencing, by End User, 2023
Figure 9: Global Market Shares for Microbiome Sequencing, by Region, 2023
Figure 10: North American Market Shares for Microbiome Sequencing, by Country, 2023
Figure 11: European Market Shares for Microbiome Sequencing, by Country, 2023
Figure 12: Asia-Pacific Market Shares for Microbiome Sequencing, by Country, 2023
Figure 13: MEA Market Shares for Microbiome Sequencing, by Region, 2023
Figure 14: South American Market Shares for Microbiome Sequencing, by Country, 2023
Figure 15: Charles River Laboratories: Revenue Shares, by Business Unit, FY 2024
Figure 16: Charles River Laboratories: Revenue Shares, by Country/Region, FY 2024
Figure 17: Danaher Corp.: Revenue Shares, by Business Unit, FY 2024
Figure 18: Danaher Corp.: Revenue Shares, by Country/Region, FY 2024
Figure 19: Eurofins Scientific: Revenue Shares, by Business Unit, FY 2023
Figure 20: Eurofins Scientific: Revenue Shares, by Country/Region, FY 2023
Figure 21: Illumina Inc.: Revenue Shares, by Business Unit, FY 2024
Figure 22: Illumina Inc.: Revenue Shares, by Country/Region, FY 2024
Figure 23: Oxford Nanopore Technologies plc: Revenue Shares, by Business Unit, FY 2024
Figure 24: Oxford Nanopore Technologies plc: Revenue Shares, by Country/Region, FY 2024
Figure 25: PacBio: Revenue Shares, by Business Unit, FY 2024
Figure 26: PacBio: Revenue Shares, by Country/Region, FY 2024
Figure 27: QIAGEN: Revenue Shares, by Business Unit, 2023
Figure 28: QIAGEN: Revenue Shares, by Country/Region, 2023
Figure 29: Thermo Fisher Scientific Inc.: Revenue Shares, by Business Unit, 2024
Figure 30: Thermo Fisher Scientific Inc.: Revenue Shares, by Country/Region, 2024

Companies Mentioned

  • BaseClear BV
  • CD Genomics
  • Charles River Laboratories
  • CosmosID
  • Crown Bioscience
  • Danaher Corp.
  • Eurofins Scientific
  • Illumina Inc.
  • Mérieux NutriSciences
  • Microbiome Insights
  • Novogene Co. Ltd.
  • Oxford Nanopore Technologies plc
  • PacBio
  • QIAGEN
  • Thermo Fisher Scientific Inc.

Table Information

Report AttributeDetails
No. of Pages124
PublishedMay 2025
Forecast Period2024 - 2029
Estimated Market Value ( USD ) in 2024 $ 1.5 Billion
Forecasted Market Value ( USD ) by 2029 $ 3.7 Billion
Compound Annual Growth Rate19.3%
Regions CoveredGlobal
No. of Companies Mentioned15

Related Topics

Related Reports

Cancer Microbiome Sequencing Market by Technology, Application, Workflow, End User, Sample Type - Global Forecast to 2030 - Product Image

Cancer Microbiome Sequencing Market by Technology, Application, Workflow, End User, Sample Type - Global Forecast to 2030

  • Report
  • 186 Pages
  • Global
From
Microbiome Sequencing Services Market by Service (Sample Preparation, Sequencing, Library Preparation), Type (Amplicon Sequencing, Whole Genome Sequencing), Technology (Sequencing by Synthesis, Nanopore Sequencing), End User - Forecast to 2028 - Product Image

Microbiome Sequencing Services Market by Service (Sample Preparation, Sequencing, Library Preparation), Type (Amplicon Sequencing, Whole Genome Sequencing), Technology (Sequencing by Synthesis, Nanopore Sequencing), End User - Forecast to 2028

  • Report
  • 193 Pages
  • Global
From
Human Microbiome-based Drugs and Diagnostics: Global Markets - Product Image

Human Microbiome-based Drugs and Diagnostics: Global Markets

  • Report
  • 116 Pages
  • Global
From
Microbiome Sequencing Services Market Report and Forecast 2024-2032 - Product Image

Microbiome Sequencing Services Market Report and Forecast 2024-2032

  • Report
  • 140 Pages
  • Global
From
Cancer Microbiome Sequencing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017 - 2027 Segmented By Component, By Technology, By Application, By End User, By company and By Region - Product Image

Cancer Microbiome Sequencing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017 - 2027 Segmented By Component, By Technology, By Application, By End User, By company and By Region

  • Report
  • 116 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.